Gianluca Vanni1, Marco Pellicciaro2, Marco Materazzo1, Valentina Bruno3, Chiara Oldani4, Chiara Adriana Pistolese5, Chiara Buonomo6, Jonathan Caspi1, Paola Gualtieri7, Agostino Chiaravalloti7,8, Leonardo Palombi7, Emilio Piccione3, Oreste Claudio Buonomo1. 1. Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy. 2. Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy marcopell62@gmail.com. 3. Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy. 4. Department of Economics and Engineering, University of Viterbo 'La Tuscia', Viterbo, Italy. 5. Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy Policlinico Tor Vergata University, Rome, Italy. 6. Department of Emergency and Admission, Critical Care Medicine, Pain Medicine and Anesthetic Science, Policlinico Tor Vergata University, Rome, Italy. 7. Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy. 8. IRCCS Neuromed, UOC Medicina Nucleare, Pozzilli, Italy.
Abstract
BACKGROUND/AIM: Coronavirus disease is spreading worldwide. Due to fast transmission and high fatality rate drastic emergency restrictions were issued. During the lockdown, only urgent medical services are guaranteed. All non-urgent services, as breast cancer (BC) screening, are temporarily suspended. The potential of breast cancer screening programs in increasing the survival rate and decreasing the mortality rate has been widely confirmed. Suspension could lead to worse outcomes for breast cancer patients. Our study aimed to analyse the data and provide estimates regarding the temporary BC screening suspension. PATIENTS AND METHODS: Data regarding breast cancer and respective screening programs were achieved through literature research and analysis. RESULTS: Considering three different scenarios with respect to the lockdown's impact on breast cancer screening, we estimate that approximately 10,000 patients could have a missed diagnosis during these 3 months. Considering a 6-month period, as suggested by the Imperial college model, the number of patients who will not receive a diagnosis will rise to 16,000. CONCLUSION: Breast cancer screening should be resumed as soon as possible in order to avoid further breast cancer missed diagnosis and reduce the impact of delayed diagnosis. Copyright
BACKGROUND/AIM: Coronavirus disease is spreading worldwide. Due to fast transmission and high fatality rate drastic emergency restrictions were issued. During the lockdown, only urgent medical services are guaranteed. All non-urgent services, as breast cancer (BC) screening, are temporarily suspended. The potential of breast cancer screening programs in increasing the survival rate and decreasing the mortality rate has been widely confirmed. Suspension could lead to worse outcomes for breast cancerpatients. Our study aimed to analyse the data and provide estimates regarding the temporary BC screening suspension. PATIENTS AND METHODS: Data regarding breast cancer and respective screening programs were achieved through literature research and analysis. RESULTS: Considering three different scenarios with respect to the lockdown's impact on breast cancer screening, we estimate that approximately 10,000 patients could have a missed diagnosis during these 3 months. Considering a 6-month period, as suggested by the Imperial college model, the number of patients who will not receive a diagnosis will rise to 16,000. CONCLUSION:Breast cancer screening should be resumed as soon as possible in order to avoid further breast cancer missed diagnosis and reduce the impact of delayed diagnosis. Copyright
Authors: O Buonomo; A Cabassi; F Guadagni; A Piazza; A Felici; R Piccirillo; G P Atzei; C Cipriani; S Schiaroli; S Mariotti; M N Guazzaroni; E Cossu; G Simonetti; E Pernazza; C U Casciani; M Roselli Journal: Anticancer Res Date: 2001 May-Jun Impact factor: 2.480
Authors: Flavia Foca; Silvia Mancini; Lauro Bucchi; Donella Puliti; Marco Zappa; Carlo Naldoni; Fabio Falcini; Maria L Gambino; Silvano Piffer; Maria E Sanoja Gonzalez; Fabrizio Stracci; Manuel Zorzi; Eugenio Paci Journal: Cancer Date: 2013-03-15 Impact factor: 6.860
Authors: Paolo Orsaria; Dimitrios Varvaras; Gianluca Vanni; Giampiero Pagnani; Jacopo Scaggiante; Federico Frusone; Alessandra Vittoria Granai; Giuseppe Petrella; Oreste Claudio Buonomo Journal: Int J Breast Cancer Date: 2014-02-11
Authors: Nino José Wilson Moterani Júnior; Vinicius César Moterani; Laura Bresciani Bento Gonçalves Moterani; Franklin Fernandes Pimentel; Francisco José Candido Dos Reis Journal: Rev Assoc Med Bras (1992) Date: 2022-05-13 Impact factor: 1.712
Authors: Michele Basilicata; Manuela Di Lauro; Vincenzo Campolattano; Giulia Marrone; Roberto Celotto; Anna Paola Mitterhofer; Patrizio Bollero; Nicola Di Daniele; Annalisa Noce Journal: Int J Environ Res Public Health Date: 2022-01-31 Impact factor: 3.390